PRESS RELEASE: New Board Member

Safest Drug Welcomes New Board Member for 2021 Term

Gaithersburg, MD (February 27, 2021) – Safest Drug is pleased to welcome Alex Evans PharmD, MBA, as a Board member for the 2021 term which started in January. In addition to Board service, Evans will be serving on the Public Relations and Communications Committee. 

“It’s exciting to add a healthcare perspective to our leadership team,” said Mika Pollack, Executive Director of Safest Drug. “We’re confident Alex will help inform our current and future program work, as well as advise us strategically on matters that support organizational growth and sustainability.”

Evans received his Bachelor of Science in Biology from the University of North Carolina-Greensboro, Doctor of Pharmacy from the University of North Carolina-Chapel Hill, and Master of Business Administration from West Texas A & M. In addition to his work as a pharmacist, with over ten years of clinical practice experience in community health and academic settings, he is also an experienced medical writer contributing to Pharmacy Times, Drug Topics, Patient Care Online, and peer-reviewed journals. In 2019, he founded, which provides community pharmacists the tools and knowledge to succeed.

Alex Evans, PharmD, MBA joined the Safest Drug Board of Directors on January 1, 2021.

“I joined Safest Drug because, as a pharmacist, I really felt connected to the mission of reducing and preventing medication harm,” Evans said. “One of our initiatives, aiming to install drug disposal bins, is a program I’ve done before at my pharmacy because I was concerned about the harms unwanted medications could pose to our community. In this position, I’m hoping to be able to further my work in medication safety.”

Safest Drug looks forward to the work Dr. Evans will be doing with the team.

(By: Esmé Parks, Writer/Contributor)

For media inquiries:

About Safest Drug 

Safest Drug is a 501(c)(3) non-profit organization. We aim to implement solutions to medication injuries and deaths in the United States with education, research, and advocacy. To learn more about our work, visit